The U.S. Food and Drug Administration (FDA) announced its plans to end the mandatory animal testing of new drugs, a move that sent AI-enabled biotech companies such as Recursion Pharmaceuticals Inc.
Hosted on MSN
Nvidia-Backed Recursion Pharma Soars After-Hours As FDA Eyes AI Over Animal Testing For Drugs: Retail Traders Elated
Shares of Recursion Pharmaceuticals Inc. rocketed over 19% in Thursday's after-hours trading, boosting retail investor sentiment, after the U.S. health regulator unveiled plans to modernize drug ...
Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback